<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04461392</url>
  </required_header>
  <id_info>
    <org_study_id>BC032020_1</org_study_id>
    <nct_id>NCT04461392</nct_id>
  </id_info>
  <brief_title>Exercise Response After Revalidation in Cancer Patients</brief_title>
  <official_title>Role of Myocardial Work in the Prediction of Cardiac Dysfunction and Response After Revalidation in Patients With Cancer Undergoing Chemotherapy and/or Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study regarding oncological patients for rehabilitation after specific cancer therapy
      involves three aims: (1) to evaluate the predictive value of myocardial work parameters on
      the improvement of exercise performance after rehabilitation, (2) to determine which
      echocardiographic parameters are more suitable in predicting cardiac dysfunction, and (3) to
      evaluate the correlation between echocardiographic parameters and fibrosis detected by
      cardiac magnetic resonance imaging (CMR).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Myocardial work (MW) provides an estimation of cardiac function by combining global
      longitudinal strain (GLS) with blood pressure values obtained non-invasively, being less load
      dependent than standard GLS. The investigator hypothesize that myocardial work could be a
      useful marker for predicting the exercise performance after chemotherapy and/or radiotherapy
      in oncological patients undergoing rehabilitation. Moreover, this study may provide
      additional information in optimal selection for rehabilitation programs.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in peak volume oxygen - VO2 (L/min)</measure>
    <time_frame>change from baseline (before rehabilitation) at 15 months (after rehabilitation)</time_frame>
    <description>represents the maximum oxygen consumption during incremental exercise that is measured during Cardiopulmonary Exercise test (CPET), being a measure of aerobic capacity of the subject</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the minute ventilation/carbon dioxide production (VE/VCO2) slope</measure>
    <time_frame>change from baseline (before rehabilitation) at 15 months (after rehabilitation)</time_frame>
    <description>this parameter shows the increase in ventilation in response to CO2 production, thus it measures the ventilatory efficiency</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the respiratory exchange ratio (RER)</measure>
    <time_frame>change from baseline (before rehabilitation) at 15 months (after rehabilitation)</time_frame>
    <description>represents the ratio between exhaled CO2 and inhale O2 may quantify the grade of the effort</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in myocardial work (MW)</measure>
    <time_frame>change from baseline (before rehabilitation) at 15 months (after rehabilitation)</time_frame>
    <description>Myocardial work (MW) is a non-invasive, less load-dependent echocardiographic parameter obtained during standard transthoracic echography using the pressure-strain loop data.
This parameter consists of the following measurements: Global constructive work (GCW) Global wasted work (GWW), Global work index (GWI), and Global work efficiency (GWE)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in health status</measure>
    <time_frame>change from baseline (before rehabilitation) at 15 months (after rehabilitation)</time_frame>
    <description>Self-assessment of the generic health status using the EQ-5D-5L questionnaire. This questionnaire assesses health status in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, on a five-level scale.
In the evaluation part, the respondents evaluate their overall health status using the visual analogue scale (EQ-VAS) from 0 ('the worst health you can imagine') - 100 ('the best health you can imagine')</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiovascular events (MACE)</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>nonfatal stroke, nonfatal myocardial infarction, and cardiovascular death</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">191</enrollment>
  <condition>Oncology</condition>
  <condition>Cardiac Toxicity</condition>
  <arm_group>
    <arm_group_label>Oncology patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients diagnosed with cancer and treated with chemotherapy and/or radiotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cardiorespiratory exercise test</intervention_name>
    <description>Cardiorespiratory exercise test to evaluate the exercise tolerance
Cardiac imaging for the assessment of the left atrium anatomy and function.</description>
    <arm_group_label>Oncology patients</arm_group_label>
    <other_name>cardiac computed tomography</other_name>
    <other_name>cardiac magnetic resonance</other_name>
    <other_name>echocardiography</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients diagnosed with cancer

          2. Undergoing chemotherapy and/or radiotherapy/hormone therapy

          3. Age older than 18 years old - maximum age of 90 years old

          4. Willing to enter revalidation in Universitair Ziekenhuis Brussel

          5. Signed consent form

        Exclusion Criteria:

          1. Severe aortic stenosis defined as aortic valve aria under 0.6 cm2/m2

          2. Supraventricular arrhythmias

          3. Poor image quality for 2D and 3D echocardiography defined as the impossibility to
             examine of more than 2 adjacent segments

          4. Resistant hypertension defined as uncontrolled blood pressure values under current
             European guidelines, Systolic Blood Pressure more than 140 mmHg and/or Diastolic Blood
             Pressure more than 80 mmHg

          5. Lung cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bernard Cosyns, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven Droogmans, Professor</last_name>
    <phone>024776009</phone>
    <email>steven.droogmans@uzbrussel.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel</name>
      <address>
        <city>Jette</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Steven Droogmans, PhD</last_name>
      <phone>024776009</phone>
      <email>steven.droogmans@uzbrussel.be</email>
    </contact>
    <contact_backup>
      <last_name>Luiza Luchian</last_name>
      <phone>024776009</phone>
      <email>marialuiza.luchian@uzbrussel.be</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GYH, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM; ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26. Erratum in: Eur Heart J. 2016 Dec 24;:.</citation>
    <PMID>27567406</PMID>
  </reference>
  <reference>
    <citation>Ferreira de Souza T, Quinaglia A C Silva T, Osorio Costa F, Shah R, Neilan TG, Velloso L, Nadruz W, Brenelli F, Sposito AC, Matos-Souza JR, Cendes F, Coelho OR, Jerosch-Herold M, Coelho-Filho OR. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease. JACC Cardiovasc Imaging. 2018 Aug;11(8):1045-1055. doi: 10.1016/j.jcmg.2018.05.012.</citation>
    <PMID>30092965</PMID>
  </reference>
  <reference>
    <citation>Piepoli MF, Abreu A, Albus C, Ambrosetti M, Brotons C, Catapano AL, Corra U, Cosyns B, Deaton C, Graham I, Hoes A, Lochen ML, Matrone B, Redon J, Sattar N, Smulders Y, Tiberi M. Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2020 Jan;27(2):181-205. doi: 10.1177/2047487319893035. Epub 2019 Dec 12.</citation>
    <PMID>31826679</PMID>
  </reference>
  <reference>
    <citation>Kosmas CE, Silverio D, Sourlas A, Montan PD, Guzman E. Role of spironolactone in the treatment of heart failure with preserved ejection fraction. Ann Transl Med. 2018 Dec;6(23):461. doi: 10.21037/atm.2018.11.16. Review.</citation>
    <PMID>30603649</PMID>
  </reference>
  <reference>
    <citation>Schrub F, Schnell F, Donal E, Galli E. Myocardial work is a predictor of exercise tolerance in patients with dilated cardiomyopathy and left ventricular dyssynchrony. Int J Cardiovasc Imaging. 2020 Jan;36(1):45-53. doi: 10.1007/s10554-019-01689-4. Epub 2019 Sep 12.</citation>
    <PMID>31515694</PMID>
  </reference>
  <reference>
    <citation>Galli E, Vitel E, Schnell F, Le Rolle V, Hubert A, Lederlin M, Donal E. Myocardial constructive work is impaired in hypertrophic cardiomyopathy and predicts left ventricular fibrosis. Echocardiography. 2019 Jan;36(1):74-82. doi: 10.1111/echo.14210. Epub 2018 Nov 29.</citation>
    <PMID>30488501</PMID>
  </reference>
  <reference>
    <citation>Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20. Erratum in: Eur Heart J. 2016 Dec 30;:.</citation>
    <PMID>27206819</PMID>
  </reference>
  <reference>
    <citation>Moneghetti KJ, Kobayashi Y, Christle JW, Ariyama M, Vrtovec B, Kouznetsova T, Wilson A, Ashley E, Wheeler MT, Myers J, Haddad F. Contractile reserve and cardiopulmonary exercise parameters in patients with dilated cardiomyopathy, the two dimensions of exercise testing. Echocardiography. 2017 Aug;34(8):1179-1186. doi: 10.1111/echo.13623. Epub 2017 Jul 6.</citation>
    <PMID>28681553</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 20, 2020</study_first_submitted>
  <study_first_submitted_qc>July 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2020</study_first_posted>
  <last_update_submitted>July 2, 2020</last_update_submitted>
  <last_update_submitted_qc>July 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Bernard Cosyns</investigator_full_name>
    <investigator_title>Head of Department</investigator_title>
  </responsible_party>
  <keyword>Echocardiography</keyword>
  <keyword>Revalidation</keyword>
  <keyword>Cardiovascular magnetic resonance imaging</keyword>
  <keyword>Oncology</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>Chemotherapy</keyword>
  <keyword>Cardiorespiratory exercise test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiotoxicity</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

